Does Rallies show Form 4 insider transactions for GNLX?

Yes. Rallies tracks GNLX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is GNLX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GNLX. It does not provide personalized investment advice.

GNLX (Genelux Corporation Common Stock) Stock Analysis - Insider Trades

Genelux Corporation Common Stock (GNLX) is a publicly traded Healthcare sector company. As of May 21, 2026, GNLX trades at $2.93 with a market cap of $127.80M and a P/E ratio of -3.41. GNLX moved +4.46% today. Year to date, GNLX is -15.80%; over the trailing twelve months it is +6.55%. Its 52-week range spans $1.99 to $8.54. Analyst consensus is strong buy with an average price target of $19.75. Rallies surfaces GNLX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading GNLX stock inside the company?

Recent GNLX insider activity includes Yu Yong sold 605, Cappello Joseph sold 605, Zindrick Thomas sold 2.80K, Smalling Ralph sold 270, and Smalling Ralph sold 240. Rallies tracks insider transaction dates, shares, prices, and estimated values.

GNLX Key Metrics

Key financial metrics for GNLX
Metric	Value
Price	$2.93
Market Cap	$127.80M
P/E Ratio	-3.41
EPS	$-0.85
Dividend Yield	0.00%
52-Week High	$8.54
52-Week Low	$1.99
Volume	0
Avg Volume	0
Revenue (TTM)	$8.00K
Net Income	$-33.58M
Gross Margin	0.00%

Recent GNLX Insider Trades

Yu Yong sold 605 (~$1.80K) on May 11, 2026.
Cappello Joseph sold 605 (~$1.80K) on May 11, 2026.
Zindrick Thomas sold 2.80K (~$8.23K) on May 11, 2026.
Smalling Ralph sold 270 (~$804.492) on May 11, 2026.
Smalling Ralph sold 240 (~$602.4) on Mar 25, 2026.

Latest GNLX News

Genelux Reports $26.3M Cash Runway into Q1 2027 and Advances Olvi-Vec Trials — May 7, 2026
Genelux Raises $18.5M, Holds $33.1M Cash with Phase 3 Readout in 2H26 — Mar 19, 2026
Genelux Prices $20M Common Stock Offering at $3.00 Per Share with 30-Day Overallotment Option — Jan 8, 2026

GNLX Analyst Consensus

4 analysts cover GNLX: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.75.

Common questions about GNLX

Who is trading GNLX stock inside the company?: Recent GNLX insider activity includes Yu Yong sold 605, Cappello Joseph sold 605, Zindrick Thomas sold 2.80K, Smalling Ralph sold 270, and Smalling Ralph sold 240. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for GNLX?: Yes. Rallies tracks GNLX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is GNLX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GNLX. It does not provide personalized investment advice.